Mannheim, Germany

Sven Sauer



 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sven Sauer

Introduction

Sven Sauer is a notable inventor based in Mannheim, Germany. He has made significant strides in the field of medical diagnostics, particularly in tumor energy metabolism profiling. His work aims to enhance the prediction of tumor prognosis and improve therapy recommendations for patients.

Latest Patents

Sauer holds a patent for a diagnostic method titled "Tumor energy metabolism profiling." This innovative approach focuses on predicting tumor prognosis, including the likelihood of metastasis, relapse, or local recurrence in tumor-related diseases in mammals. The method involves determining the enzyme activity of key enzymes in fresh tumor tissue or cell mass after a 24-hour incubation in a cell culture medium. This incubation minimizes the effects of nutrition, drugs, and biopsy or surgery on the energy metabolism of the tissue slices or cell mass. The resulting quotients of anaerobic enzyme activity are compared to aerobic enzyme activity, providing valuable insights for prognosis and therapy recommendations.

Career Highlights

Sven Sauer's career is marked by his dedication to advancing medical diagnostics. His innovative patent reflects his commitment to improving patient outcomes through scientific research and development. Working at Universität Heidelberg, he has contributed to the academic and medical community through his research and inventions.

Collaborations

Sauer collaborates with esteemed colleagues, including Wilfried Roth and Georg Gdynia. Their combined expertise enhances the research and development efforts in the field of tumor diagnostics.

Conclusion

Sven Sauer's contributions to tumor energy metabolism profiling represent a significant advancement in medical diagnostics. His innovative approach has the potential to improve patient care and outcomes in tumor-related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…